Using Bcl-xL anti-apoptotic protein for altering target cell apoptosis

Electronic Journal of Biotechnology

Volumn 15, Issue 5, 2012, Pages 2-

  Iz, Sultan Gülçe ^a   Çalimlioǧlu, Beste ^a,b   Gürhan, Saime Ismet Deliloǧlu ^a  

^a EGE UNIVERSITY   (Turkey)

^b ISTANBUL MEDENIYET UNIVERSITY   (Turkey)

Author keywords

Animal cell biotechnology; Apoptosis; Bcl xL anti apoptotic protein

Indexed keywords

ANIMAL CELLS; ANTI-APOPTOTIC PROTEIN; APOPTOSIS INDUCTION; APOPTOTIC CELLS; BIOPHARMACEUTICAL PROTEINS; BIOTECHNOLOGICAL APPLICATIONS; CAMPTOTHECIN (CPT); CELL SURVIVAL; CELL VIABILITY; DNA VACCINATION; DNA VACCINE; DOXORUBICIN; EMPTY VECTOR; ENHANCED GREEN FLUORESCENCE PROTEINS; IN-VITRO; MULTIPLE CLONING; RECOMBINANT PROTEIN PRODUCTIONS; SERUM DEPRIVATION; TARGET CELL APOPTOSIS; TRANSFECTED CELLS; TRANSIENT EXPRESSION; VECTOR SYSTEMS;

BODY FLUIDS; CELL CULTURE; CELL PROLIFERATION; DNA; FLOW CYTOMETRY; GENES; GENETIC ENGINEERING; RECOMBINANT PROTEINS; VACCINES; VECTORS;

CELL DEATH;

CAMPTOTHECIN; CASPASE 3; DOXORUBICIN; ENHANCED GREEN FLUORESCENT PROTEIN; PROTEIN BCL XL; RECOMBINANT PROTEIN; VIRUS VECTOR;

ANIMAL CELL; ANTI APOPTOTIC ACTIVITY; APOPTOSIS; ARTICLE; BCL XL GENE; CELL PROTECTION; CELL STRAIN BHK; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; DNA IMMUNIZATION; DRUG ACTIVITY; DRUG TARGETING; EXPRESSION VECTOR; FLOW CYTOMETRY; GENE; GENE INSERTION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HAMSTER; IC 50; IN VITRO GENE TRANSFER; IN VITRO STUDY; INTERNAL RIBOSOME ENTRY SITE; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMID; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; TRANSIENT TRANSFECTION; VIRAL GENE THERAPY; CELL POPULATION; ENZYME MODIFICATION; GENE EXPRESSION REGULATION; GENE STRUCTURE; PROTEIN BCL XL GENE; TRANSIENT EXPRESSION;

ANIMALIA; CYTOMEGALOVIRUS;

EID: 84866628690     PISSN: None     EISSN: 07173458     Source Type: Journal    
DOI: 10.2225/vol15-issue5-fulltext-2     Document Type: Article

References (32)

1. Akiyama, M.; Yamada, O.; Kanda, N.; Akita, S.; Kawano, T.; Ohno, T.; Mizoguchi, H.; Eto, Y.; Anderson, K.C. and Yamada, H. (2002). Telomerase overexpression in K562 leukemia cells protects against apoptosis by serum deprivation and double-stranded DNA break inducing agents, but not against DNA synthesis inhibitors. Cancer Letters, vol. 178, no. 2, p. 187-197.[CrossRef]
2. Al-Rubeai, M. and Singh, R.P. (1998). Apoptosis in cell culture. Current Opinion in Biotechnology, vol. 9, no. 2, p. 152-156. [CrossRef]
3. Andersen, D.C. and Krummen, L. (2002). Recombinant protein expression for therapeutic applications. Current Opinion in Biotechnology, vol. 13, no. 2, p. 117-123. [CrossRef]
4. Baik, J.Y. and Lee, G.M. (2009). A DIGE approach for the assessment of differential expression of the CHO proteome under sodium butyrate addition: Effect of Bcl-xl overexpression. Biotechnology and Bioengineering, vol. 105, no. 2, p. 358-367. [CrossRef]
5. Blömer, U.; Kafri, T.; Randolph-Moore, L.; Verma, I.M. and Gage, F.H. (1998). Bcl-xL protects adult septal cholinergic neurons from axotomized cell death. Proceedings of the National Academy of Sciences of the United States of America, Neurobiology, vol. 95, no. 5, p. 2603-2608. [CrossRef]
6. Brunelle, J.K. and Zhang, B. (2010). Apoptosis assays for quantifying the bioactivity of anticancer drug products. Drug Resistance Updates, vol. 13, no. 6, p. 172-179. [CrossRef]
7. El-Assaad, W.; El-Sabban, M.; Awaraji, C.; Abboushi, N. and Dbaibo, G.S. (1998). Distinct sites of action of Bcl-2 and Bcl-xL in the ceramide pathway of apoptosis. Biochemical Journal, vol. 336, no. 3, p. 735-741.
8. Fiebig, A.A.; Zhu, W.; Hollerbach, C.; Leber, B. and Andrews, D.W. (2006). Bcl-xL is qualitatively different from and ten times more effective than Bcl-2 when expressed in a breast cancer cell line. BMC Cancer, vol. 6, no. 213. [CrossRef]
9. Figueroa, B.; Sauerwald, T.M.; Oyler, G.A.; Hardwick, J.M. and Betenbaugh, M.J. (2003). A comparison of the properties of a Bcl-xL variant to the wild-type anti-apoptosis inhibitor in mammalian cell cultures. Metabolic Engineering, vol. 5, no. 4, p. 230-245. [CrossRef]
10. Figueroa, B.; Chen, S.; Oyler, G.A.; Hardwick, M. and Betenbaugh, M.J. (2004). Aven and Bcl-xL enhance protection against apoptosis for mammalian cells exposed to various culture conditions. Biotechnology and Bioengineering, vol. 85, no. 6, p. 589-600. [CrossRef]
11. Han, Y.K.; Ha, T.K.; Kim, Y.G. and Lee, G.M. (2011). Bcl-xL overexpression delays the onset of autophagy and apoptosis in hyperosmotic recombinant Chinese hamster ovary cell cultures. Journal of Biotechnology, vol. 156, no. 1, p. 52-55. [CrossRef]
12. Hirsch, T.; Decaudin, D.; Susin, S.; Marchetti, P.; Larochette, N.; Resche-Rigon, M. and Kroemer, G. (1998). PK11195, a ligand of the mitochondrial benzodiazepine receptor, facilitates the induction of apoptosis and reverses Bcl-2-mediated cytoprotection. Experimental Cell Research, vol. 241, no. 2, p. 426-434. [CrossRef]
13. Huang, J.; Ito, Y.; Morikawa, M.; Uchida, H.; Kobune, M.; Sasaki, K.; Abe, T. and Hamada, H. (2003). Bcl-xL gene transfer protects the heart against ischemia/reperfusion injury. Biochemical and Biophysical Research Communications, vol. 311, no. 1, p. 64-70. [CrossRef]
14. Huang, J.; Nakamura, K.; Ito, Y.; Uzuka, T.; Morikawa, M.; Hirai, S.; Tomihara, K.; Tanaka, T.; Masuta, Y.; Ishii, K.; Kato, K. and Hamada, H. (2005). Bcl-xL gene transfer inhibits bax translocation and prolongs cardiac cold preservation time in rats. Circulation, vol. 112, no. 1, p. 76-83. [CrossRef]
15. Huang, B.; Mao, C.P.; Peng, S.; He, L.; Hung, C.F. and Wu, T.C. (2007). Intradermal administration of DNA vaccines combining a strategy to bypass antigen processing with a strategy to prolong dendritic cell survival enhances DNA vaccine potency. Vaccine, vol. 25, no. 45, p. 7824-7831. [CrossRef]
16. Kaufmann, S.H. and Earnshaw, W.C. (2000). Induction of apoptosis by cancer chemotherapy. Experimental Cell Research, vol. 256, no. 1, p. 42-49. [CrossRef]
17. Kim, N.S. and Lee, G.M. (2000). Overexpression of bcl-2 inhibits sodium butyrate induced apoptosis in Chinese hamster ovary cells resulting in enhanced humanized antibody production. Biotechnology and Bioengineering, vol. 71, no. 3, p. 184-193. [CrossRef]
18. Kim, T.W.; Hung, C.F.; Zheng, M.; Boyd, D.A.K.; He, L.; Pai, S.I. and Wu, T.C. (2004). A DNA vaccine coexpressing antigen and an anti-apoptotic molecule further enhances the antigen-specific CD8+ T-cell immune response. Journal of Biomedical Science, vol. 11, no. 4, p. 493-499. [CrossRef]
19. Kim, J.H.; Chen, J.; Majumder, N.; Lin, H.; Falo, L.D. and You, Z. (2005). 'Survival gene' Bcl-xl potentiates DNA-raised antitumor immunity. Gene Therapy, vol. 12, no. 20, p. 1517-1525. [CrossRef]
20. Kim, Y.G.; Kim, J.Y.; Mohan, C. and Lee, G.M. (2009). Effect of Bcl-xL overexpression on apoptosis and autophagy in recombinant Chinese hamster ovary cells under nutrient-deprived condition. Biotechnology and Bioengineering, vol. 103, no. 4, p. 757-766. [CrossRef]
21. Kim, Y.G.; Kim, J.Y.; Park, B.; Ahn, J.O.; Jung, J.K.; Lee, H.W.; Lee, G.M. and LEE, E.G. (2011). Effect of BclxL overexpression on erythropoietin production in recombinant Chinese hamster ovary cells treated with dimethyl sulfoxide. Process Biochemistry, vol. 46, no. 11, p. 2201-2204.[CrossRef]
22. Kutuk, O.; Temel, S.G.; Tolunay, S. and Basaga, H. (2010). Aven blocks DNA damage-induced apoptosis by stabilising Bcl-xL. European Journal of Cancer, vol. 46, no. 13, p. 2494-2505. [CrossRef]
23. Liew, J.C.J.; Tan, W.S.; Alitheen, N.B.M.; Chan, E.S. and Tey, B.T. (2010). Over-expression of the X-linked inhibitor of apoptosis protein (XIAP) delays serum deprivation-induced apoptosis in CHO-K1 cells. Journal of Bioscience and Bioengineering, vol. 110, no. 3, p. 338-344. [CrossRef]
24. Lindenboim, L.; Diamond, R.; Rothenberg, E. and Stein, R. (1995). Apoptosis induced by serum deprivation of PC12 cells is not preceded by growth arrest and can occur at each phase of the cell cycle. Cancer Research, vol. 55, no. 6, p. 1242-1247.
25. Majors, B.S.; Betenbaugh, M.J.; Pederson, N.E. and Chiang, G.G. (2008). Enhancement of transient gene expression and culture viability using Chinese hamster ovary cells overexpressing Bcl-xL. Biotechnology and Bioengineering, vol. 101, no. 3, p. 567-578. [CrossRef]
26. Mastrangelo, A.J.; Hardwick, J.M.; Bex, F. and Betenbaugh, M.J. (2000). Part I. Bcl-2 and bcl-xL limit apoptosis upon infection with alphavirus vectors. Biotechnology and Bioengineering, vol. 67, no. 5, p. 544-554. [CrossRef]
27. Mhawi, A.A. (2009). Interaction of doxorubicin with the subcellular structures of the sensitive and Bcl-xLoverexpressing MCF-7 cell line: Confocal and low-energy-loss transmission electron microscopy. Micron, vol. 40, no. 7, p. 702-712. [CrossRef]
28. Park, S.S.; Kim, M.A.; Eom, Y.W. and Choi, K.S. (2007). Bcl-xL blocks high dose doxorubicin-induced apoptosis but not low dose doxorubicin-induced cell death through mitotic catastrophe. Biochemical and Biophysical Research Communications, vol. 363, no. 4, p. 1044-1049. [CrossRef]
29. Qian, Y.H.; Xiao, Q.; Chen, H. and Xu, J. (2009). Dexamethasone inhibits camptothecin-induced apoptosis in C6-glioma via activation of Stat5/Bcl-xL pathway. Biochimica et Biophysica Acta (BBA)-Molecular Cell Research, vol. 1793, no. 5, p. 764-771. [CrossRef]
30. Thai, K.; Choi, J.; Franzin, C.M. and Marassi, F.M. (2005). Bcl-XL as a fusion protein for the high-level expression of membrane-associated proteins. Protein Science, vol. 14, no. 4, p. 948-955. [CrossRef]
31. Yang, Y.; Xiong, Z.; Zhang, S.; Yan, Y.; Nguyen, J.; Bernard, N.G.; Huifang, L.U.; Brendese, J.; Yang, F.; Wang, H. and Yang, X.F. (2005). Bcl-xL inhibits T-cell apoptosis induced by expression of SARS coronavirus E protein in the absence of growth factors. Biochemical Journal, vol. 392, p. 135-143. [CrossRef]
32. Zustiak, M.P.; Pollack, J.K.; Marten, M.R. and Betenbaugh, M.J. (2008). Feast or famine: Autophagy control and engineering in eukaryotic cell culture. Current Opinion in Biotechnology, vol. 19, no. 5, p. 518-526. [CrossRef]